Table 2 Statistics for positive control data obtained in this study
Statistics | TA100 | TA98 | TA1535 | TA1537 | WP2uvrA | |||||
|---|---|---|---|---|---|---|---|---|---|---|
-S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | |
Positive control article and dose (μg/plate) | AF-2 (0.01) | 2AA (1.0) | AF-2 (0.1) | 2AA (0.5) | SA (0.5) | 2AA (2.0) | 9AA (80) | 2AA (2.0) | AF-2 (0.01) | 2AA (10) |
No. of data | 27 | 27 | 27 | 27 | 26 | 26 | 26 | 26 | 24 | 24 |
Mean | 541 | 1028 | 481 | 386 | 376 | 265 | 331 | 167 | 133 | 650 |
SD | 157.23 | 331.4 | 119.21 | 128.07 | 108.98 | 93.99 | 150.7 | 65.38 | 41.60 | 282.98 |
Min | 336 | 521 | 217 | 166 | 135 | 93 | 121 | 61 | 74 | 200 |
Max | 937 | 1656 | 684 | 611 | 593 | 488 | 671 | 368 | 243 | 1285 |
Kurtosis | 0.13 | −1.28 | −0.30 | −1.09 | −0.03 | −0.01 | 0.00 | 2.17 | 0.80 | −0.23 |
Skewness | 0.80 | 0.25 | −0.45 | 0.05 | −0.21 | 0.15 | 0.67 | 0.89 | 1.05 | 0.55 |
2SD- | 226 | 365 | 243 | 130 | 158 | 77 | 29 | 36 | 50 | 84 |
2SD+ | 855 | 1691 | 719 | 643 | 594 | 453 | 632 | 298 | 216 | 1216 |
3SD- | 69 | 34 | 123 | 2 | 49 | −17 | − 122 | −29 | 8 | −199 |
3SD+ | 1013 | 2022 | 839 | 771 | 703 | 547 | 783 | 363 | 258 | 1499 |